non-ST-elevation acute coronary syndrome
1 paper
- Humans1
Trial sponsors
1 trialPhase 41,350 people
Latest
1 in 12 monthsFrontiers in Cardiovascular Medicine
Early evolocumab improves lipid profile, inflammation and short-term outcomes in non-revascularized CHIP-NSTEACS patients: a retrospective cohort study
Cohort study of 186 peopleEvolocumab